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1. Abstract 
In order to reliably assess the risk of adverse systemic effects of chemicals by 
using in vitro methods, there is a need to simulate their absorption, distribution, 
metabolism, and excretion (ADME) in vivo to determine the target organ 
bioavailable concentration, and to compare this predicted internal concentration 
with an effective internal concentration. The effective concentration derived from 
in vitro toxicity studies should ideally take into account the fate of chemicals in 
the in vitro test system, since there can be significant differences between the 
applied nominal concentration and the in vitro bioavailable concentration. 
Whereas PBK models have been developed to simulate ADME properties in vivo, 
the Virtual Cell Based Assay (VCBA) has been developed to simulate in vitro 
fate. In this project, the VCBA model in R code, was applied to better interpret 
previously obtained in vitro acute toxicity data and study how they can be 
compared to results from acute toxicity in vivo.  
 
For 178 chemicals previously tested in vitro with the 3T3 BALB/c cell line using 
the Neutral Red Uptake cytotoxicity assay, physicochemical parameters were 
retrieved and curated. Of these chemicals, 83 were run in the VCBA to simulate 
a 96-well microplate set up with 5% serum supplementation, and their no effect 
concentration (NEC) and killing rate (Kr) optimized against the experimental 
data. Analyses of results of partitioning of the chemicals show a strong relation 
with their lipophilicity, expressed here as the logarithm of the octanol/water 
partitioning coefficient, with highly lipophilic chemicals binding mostly to medium 
lipid. Among the chemicals analysed, only benzene and xylene were modelled to 
evaporate by more than 10 %, and these were also the chemicals with highest 
degradation rates during the 48 hours assay. Chemical degradation is dependent 
not only on the air and water degradation rates but also on the extent of binding 
of the chemical.  
 
Due to the strong binding of some chemicals to medium lipids and proteins we 
analysed the impact of different serum supplementations (0%, 5% and 10%) on 
the chemical dissolved concentrations.  As expected, for the more lipophilic 
chemicals, different serum levels result in different dissolved concentrations, 
with lipid and protein binding reducing chemical loss by evaporation. Still the 
lack of saturation modelling might mislead the 0 % supplementation since the 
lipids coming solely from cells exudates are able to sequester chemical to a large 
extent, eg. after 48 hours, 63% (1.2E-5 M) of dimethyldioctadecylammonium 
chloride was bound to lipid from the cells. Although highly lipophilic chemicals 
have a very small bioavailable fraction, cellular uptake rate is also dependent on 
logKow, which compensates for this lack of bioavailability to some extent. 
 
Based on the relevance of lipophilicity on in vitro chemical bioavailability, we 
have developed an alert system based on logKow, creating four classes of 
chemicals for the experimental condition with 10% serum supplementation: 
logKow 5- 10 (A), logKow <5 (B), logKow <2.5 (C), and logKow <2 (D). New 
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chemicals from Classes A and B, which will in the future be tested in vitro, were 
run first on the VCBA, without considering toxicity (NEC and Kr set to 0). VCBA 
simulations indicated that these chemicals are more than 50% bound to medium 
proteins, lipids and plastic. Therefore, for chemicals with logKow falling in these 
classes, special care should be taken when extrapolating the obtained in vitro 
toxic concentrations to in vivo relevant doses.  
 
A comparison of the VCBA-predicted dissolved concentrations corresponding to 
nominal IC50 values with the available rat oral LD50 values did not improve the 
previously obtained correlations. This is probably because other in vivo kinetic 
processes play an important role but were not considered in this in vitro-in vivo 
extrapolation. 
 
The comparison of the VCBA predicted IC50 dissolved concentrations with the 
available rat oral LD50 values, did not improve the previously obtained 
correlations. Nevertheless, other in vivo kinetic processes that are not modelled 
may play an important role. They should be considered in the in vitro-in vivo 
extrapolations. 
 
A local sensitivity analysis showed the relative low impact of Molar Volume and 
Molecular Diffusion Volume on the final dissolved concentration, supporting the 
use of approximated values obtained through the herein created QSARs. The 
logkow and Henry Law Constant showed, as expected, a high impact in 
partitioning. Killing rate was shown to also have a relative low impact in the final 
chemical concentration, indicating that although its optimization is important, 
finding the Kr that leads to the absolute best correlation between experimental 
and predicted concentration-viability curves, is not imperative.  
 
The VCBA can be applied to virtually any chemical as long as the 
physicochemical data (for the fate model) and the experimental toxicity data 
(that include cell growth/death) are available. However, being such a generic 
model, several assumptions had to be made: i) no distinction of chemical classes 
(inorganic, polar organic chemicals), ii) no consideration of metabolism, iii) 
saturation kinetics and iv) external in vitro conditions. 
 
The advantages of having a generic model are that the VCBA can fit several 
experimental set ups and should be used in an exploratory manner, to help 
refinement of experimental conditions. The herein obtained VCBA results should 
be double checked experimentally the partition with a set of chemical 
compounds to better understand to what extent VCBA represents chemicals of 
different properties.  
 
In future developments, it would be important to reduce the uncertainties of the 
model such as binding-saturation and consider inclusion of other endpoints such 
as metabolic activity. 
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2. Introduction 
Global production of chemicals has increased from 1 million tonnes in 1930 to 
400 million tonnes in 2001, with some of these new chemicals constituting a 
hazard to human health and the environment. To obtain information on 
chemicals on the EU market, and to determine the risks they may pose, the 
REACH (Registration, Evaluation, Authorisation and Restriction of Chemicals) 
Regulation was implemented, under which all chemicals that are produced 1 
tonne or more per year need to be registered1. This includes the requirement for 
manufacturers and importers to gather information on the properties of their 
chemical substances. Although issues around animal experimentation have 
already been recognized for some years with Russell and Burch elaboration of 
3Rs principles (replacement, reduction and refinement) in 1959, risk assessment 
of chemicals has a long history of relying on animal models. REACH promotes 
the use of alternative tests for the generation of information on intrinsic 
properties of substances (article 13), and efforts have been made to develop and 
show the potential of alternatives to animal experimentation methods.  
In vitro models have been emerging as the main animal experimental 
alternatives, offering the possibility of using several types of animal and human 
cells. Considering that toxicological events initiate mostly at a cellular level2,3, 
these models are highly relevant as they can give further insights of toxic 
mechanisms. Nevertheless, in vitro toxicity data should not be directly compared 
to in vivo data due to the fact that complex biokinetic and toxicodynamic 
processes that occur in vivo resulting in a heterogeneous chemical distribution in 
the animal or human's body, cannot be captured as such in an in vitro system. 
 
To convert the in vitro concentration-response curve and median inhibitory 
concentration (IC50) into more relevant doses for human risk and safety 
assessment (e.g. in vivo median Lethal Dose (LD50)), in silico physiologically-
based kinetic (PBK) modelling have been created. PBK models consist in sets of 
differential equations that simulate pharmacokinetic processes such as 
absorption, distribution, metabolism, and excretion (ADME). Thus, these in silico 
models allow both the calculation from the nominal in vivo dose to the target-
organ bioavailable concentration and consequently the extrapolation from in 
vitro to in vivo (IVIVE) 4–7.  
 
In this context, several PBK models have been developed, most of which are 
compiled in Lu et al.8 The integration of in vitro toxicity data and these models 
has been indeed indicating a good correlation between the  prediction and 
experimental concentrations for animal and human toxicity 9–11. 
 
This integration of in vitro and in silico (including PBK models) was the approach 
used by Gubbels van Hal et al 12 to analyse a set of 10 compounds. This work 
showed that it was possible to decrease by 38% the number of the animals 
used. Still, one of the endpoints which showed to be more difficult to evaluate 
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without the use of animal data, was acute oral toxicity in which half of the 
compounds had their toxicity over-estimated.  
 Although integration of these modelling techniques allows accounting for the in 
vivo toxicokinetics, approximating the toxic doses obtained in the different 
models, in vitro cells are still in a different microenvironment, as it is herein 
illustrated:  
 
i) Underrepresentation of the toxicological targets, some of which require multi-
organ interactions, thus not captured in an in vitro system. 
ii) Incomplete differentiation into organ specific phenotypes, making metabolism 
and clearance, hallmarks troublesome to represent 13–15.  
iii) Although reduced, there are some pharmacokinetic processes in vitro, such as  
binding to the supplemented serum proteins and lipids 16,17, binding to plastic 
18 and evaporation, which do not occur in vivo.  
iv) Frequently the dose metric used in in vitro systems is concentration, which 
does not reflect the amount of compound per number of cells. Gulden et al, 
2001 showed that cell quantity does change the free concentration and toxic 
effects, with higher cell numbers in culture having higher IC50 values
19. 
 
While solutions to the points i) and ii) pass through more sophisticated in vitro 
technologies such as body-on-a-chip, and more refined techniques of 
differentiation, the last two points are an issue of dosimetry/kinetics. 
 
Therefore, a better approximation to in vivo might be obtained if these in vitro 
biokinetic processes are modulated, determining the concentration that is 
effectively dissolved in the exposure medium and unbound (free concentration). 
This simulation might reduce the gap between the in vitro and the in vivo freely 
available plasma concentration, especially for highly volatile and/or lipophilic 
chemical compounds.  
Hence, several in vitro kinetic models have been developed as summarized in 
Table 1, which shows the different focus and design of these models. 
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Table 1 -List of published references which characterize the fate of a chemical in in vitro cell lines. 
Legend: Sin- Single Exposure, Rep- Repeated exposure, PHH-Primary Human Hepatocytes; PRH-
Primary Rat Hepatocytes; HepaRG- Human hepatic stem cell line; HepG2- Human hepatocellular 
carcinoma-derived cell line; RTL-W1 and Rtgill-W1- Rainbow trout cell lines; BALB 3T3- Mouse 
fibroblast cell line; HEK293- Human embryonal kidney cell line; A549- Human adenocarcinoma-
derived alveolar basal epithelial cell line; MCF-7- human breast adenocarcinoma cell line 
Model 
Cell Type Chemical(s) 
Exposure Dynamic 
endpoint: 
cell 
viability 
Ref. 
Compartments 
Kinetic 
elements 
Sin. Rep. 
Cell 
Membrane  
Medium 
Lipid and 
Protein 
HEK293T 
HEK293H 
HepG2, 
HCT116 
ME-180 
100 chemicals from 
neutral to ionogenic 
X   20 
VCBA 
Cell,  
Medium 
Headspace 
Serum lipid 
Serum 
Protein, 
Plastic,         
Water and 
Air 
Degradation, 
Dissolved 
organic 
matter (cell 
exudates) 
3T3 
HepaRG 
HepG2 
A549 
Any as long the 
respective physical-
chemical 
parameters are 
found. 
X X X 21, 51 
Cell 
 Medium 
 
ECM 
proteins; 
Metabolism 
PHH 
PRH 
HepaRG 
Ibuprofen X X 
X 
 
22 
Cells,  
Medium  
Headspace 
Plastic 
RTgill-W1 
 
Imidacloprid, 
Dimethoate, 
Carbendazim, 
Malathion, 
Cyproconazole, 
Propiconazole, 
Pentachlorophenol, 
Cypermethrin,  
1,2,3-
Trichlorobenzene, 
Naphtalene, 
Hexachlorobenzene 
X   23 
Cells/tissue 
Medium  
 Headspace 
Serum , 
Plastic,    
Water 
solubility, 
dissolved 
organic 
matter, 
Any Any x   24 
Cells  
Medium 
Plastic; 
Metabolism 
via clearance 
PRH 
HepaRG 
Chlorpromazine X X  25 
Cells,  
Medium 
Headspace 
Protein, 
Plastic 
BALB 3T3 
RTgill-W1 
Phenanthrene X  X 18 
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As an example, Heringa et al 28 showed to have obtained better correlations 
between in vivo and in vitro toxic potencies when the calculated freely available 
concentrations were used as measure of the cytotoxic potency instead of the 
nominal concentrations. The relevance of toxicokinetic modelling is further 
highlighted by the fact that the partition with other cell culture components has 
a special great impact in compounds with higher cytotoxicity potencies. The 
quantity of non-bioavailable compound can easily surpass the bioavailable one. 
In the case of less toxic compounds, the impact of serum binding may be 
negligible if the nominal toxic concentration exceeds the binding capacity of the 
serum proteins 29.  
 
Model 
Cell Type Chemical(s) 
Exposure 
Dynamic 
endpoint: 
cell 
viability 
 
Ref 
Compartments 
Kinetic 
elements 
Sin. Rep. 
Cells 
Medium 
Headspace 
Protein, 
Plastic 
RTL-W1 
RTgill-W1 
Benzo(a)pyrene, 
1,2-
dichlorobenzene, 
and 1,2,4-
trichlorobenzene 
 X X 26 
Medium, 
Cells/tissue 
Protein 
MCF-7 
cells 
Genistein, bisphenol 
A, Octylpneol 
X   27 
 Cells, 
Medium 
 HEK293 
[3H]estradiol, 
octylphenol. 
X   28 
 Cells, 
Medium  
 Culture Vessel 
 
Sperm 
cells 
Antimycin A, 
digitonin, 
thioridazine HCl, 
hexachlorophene 
4,4′-DDE, dieldrin, 
pentachlorophenol, 
methylmercury, 
chloride and xylene 
and 1-
nitronaphthalene 
X   19 
Headspace exchange 
Media Lipid 
and Protein 
binding 
Plastic 
binding 
Inter Cells exchange 
Chemical 
Figure 1. Schematic representation of the Fate and Transport model of the virtual cell based 
assay (VCBA) that simulates the kinetics of a chemical tested.  
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The Virtual Cell Based Assay (VCBA) is another of these in silico models that 
simulates the chemical fate in vitro, and was developed as part of the EU FP7 
COSMOS project (http://www.cosmostox.eu) to clarify the actual bioavailable 
concentration required to cause perturbations in cells 30,31. Briefly, this model is 
represented in Figure 1 and consists of 4 interconnected models: 
 
 [1] Fate and transport model, is based on each compound physical-
chemical properties. It describes the dynamic mass balance of compound with 
its  partition between headspace (gas exchange equations), plastic and serum 
lipid and protein 16,26 and compound degradation;  
[2] Cell partitioning model, which accounts for cells uptake/excretion 
and intracellular partition between lipid, protein and aqueous fractions which 
depends on the chemical characteristics and cell type composition; 
[3] Cell growth and division model, which is simulated through a 4-
staged (G1, S, G2 and M cell cycle phases) approach using a Leslie Matrix;  
[4] Toxicity and effects model, which merges the experimental in vitro 
obtained concentration-response curve with the cell growth and division model 
to optimize the toxicity parameters, Killing rate(Kr) and No-Effect Concentration 
(NEC); 
Additionally, the VCBA takes into account the experimental set up, which 
includes the well shape and size, the volume of media and the amount of 
supplemented serum and, thus, protein and lipid content in the media. 
The mathematical equation describing the four  interconnected models of the 
VCBA are reported in Zaldivar et al.21 To run the VCBA specific inputs 
parameters for chemicals, cell types and experimental set up are needed. Herein 
we aimed to analyse 178 compounds used in international projects and 
validation studies [NICEATM/ECVAM validation study (NIH, 2006); the PF6 EU 
project ACuteTox (http://www.acutetox.eu/; Prieto et al., 2013a); ECVAM 
validation study (Prieto et al., 2013b] where the cell line BALB/c 3T3 was used 
and cytotoxicity was measured with a Neutral Red Uptake (NRU) assay. In the 
ACuteTox project the in vitro cytotoxicity assay was complemented with specific 
target organ in vitro assays in an attempt to improve the prediction of human 
acute oral systemic toxicity. With regard to classification of compounds into 
acute oral toxicity categories according to the EU CLP Regulation (Classification, 
Labelling and Packaging of Substances and Mixture), the results showed 
difficulties in predicting the 4 toxicity categories with any of the proposed 
combinations. Nevertheless, substances belonging to the non-classified group 
(LD50 >2000mg/kg) were predicted relatively well, with a false negative rate 
lower than 5 %32. To rationalize the true/false predictions obtained, kinetic 
parameters should be considered as recommended in the EURL ECVAM strategy 
to replace, reduce and refine the use of animals in the assessment of acute 
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mammalian toxicity33. With this in mind, the value of the kinetic simulations 
obtained with the VCBA model has been explored. 
The overall goal of this work was to i) clean, harmonize and evaluate the 
previous VCBA model code; ii) retrieve the physicochemical parameters of 178 
compounds, iii) optimize and run the model, obtaining the concentration of 
compounds partition in the several elements/compartments of the in vitro assay. 
iv) to analyse if the calculated dissolved and unbound IC50 correlates better with 
the in vivo LD50 than the nominal IC50, possibly explaining the misclassifications 
obtained with the 3T3 NRU cytotoxicity assay. Furthermore, we used the VCBA 
to help identifying compounds prone to have an in vitro determined toxic 
concentration, very discrepant from the in vivo one and that may offer specific 
difficulties in vitro. We also propose a simple approach, as a system based on 
LogKow, to understand chemical's fate 
10 
 
3. Methodology 
 
To run the Virtual Cell Based Assay (VCBA) selected physical-chemical 
parameters are required: molecular weight, molecular diffusion volumes 
(indicates as atomic diffusion in Zaldivar et al., in press), molar volume, Henry 
law constant and degradation rate in water and air and the logarithm of octanol-
water partition (LogKow). Although for several compounds data reported were 
obtained experimentally, for some others only predictions were available. In 
case of predictions different values were often reported, and the choice of the 
prediction method must be carefully addressed.  
The web based chemical databases Chemical Dashboard 
(https://comptox.epa.gov/dashboard) and Chemspider 
(http://www.chemspider.com/) were used for searching these parameters. While 
CompTox Dashboard has its own predictive tools, Chemspider (Royal Society of 
Chemistry) relies on the prediction tools EPI Suite™ (US Environmental 
Protection Agency's), ACD/LABS and Chemicalize. The time frame of search 
was from July to October 2016. 
 
Table 2 - Web chemicals databases/prediction tools used to retrieve each chemical parameter. 
 Chemspider Chemical Dashboard 
Parameter: Exp. Pred. Exp. Pred. 
 EPI Suite  ACD/Labs Chemicalize 
LogKow X X X X X X X 
Henry Law 
Constant 
 X X   X X 
Air and Water 
half life 
  X     
Molar Volume    X    
Molecular 
Weight 
     X 
Molecular 
Diffusion 
Volume 
Fuller Method of atomic diffusion volume increments addition 
 
For each chemical parameter, Table 2 summarizes the selected database where 
the values were retrieved; LogKow was found both on Chemspider (ACD/LABS, 
EPI Suite and/or Chemicalize) and Chemical Dashboard.  
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Water and air degradation rates (s-1) were calculated from the compounds' half-
life (hr) in water and air, parameters retrieved from EPIsuite, database available 
online through Chemspider. Molar Volume was retrieved from Chemspider as 
well, more specifically from ACD/Labs.   
Both experimental and predicted values of Henry law constant (HLC) were 
available in both Chemspider (EPIsuite) and Chemical Dashboard, although in 
the latter the values were removed in August 2016, being reposted only after a 
few months. Values were converted atm*m3/mol. to Pa*m3/mol. 
 
3.1. Molecular Diffusion Volumes 
Molecular diffusion volumes (dimensionless) were calculated following Fuller 
semi-empirical method which consists in the sum of the specific atomic diffusion 
volumes and discounting the volume for each aromatic/heterocyclic ring 34,35. 
Atomic and Structural Diffusion Volume increments 
 Fuller, 1966 Fuller, 1969  Fuller, 1966 Fuller, 1969 
 
C 16.5 15.9 F 8.78 14.7 
H 1.98 2.31 Cl 19.5 21.0 
O 5.48 6.11 Br 33.6 21.9 
N 5.69 4.54 I - 29.8 
Aromatic 
Ring 
-20.2 -18.3 S 17 22.9 
Heterocyclic 
Ring 
-20.2 -18.3    
 
Although, initially the atomic increments used21 were from Fuller et al, 1966, 
slightly different increments in Fuller et al, 1969 were posteriorly found. Both 
increments are shown in Table 3. In spite of being regarded36 as a precise 
method, predicting the diffusion coefficients of organic compounds with errors of 
<10%, its use is limited to molecules that are solely composed by the tabled 
atoms. Also, it is noteworthy that the method is not as precise with inorganic 
compounds, where the prediction is ±30 % of the measured values37. 
For 37 compounds among the 178 would require the additional Atom Diffusion 
Volumes increments: B, Na, Cd, Pt, P, Cu, Fe, Hg, K, Se, Tl and Zn. The 
similarity to Molecular Weight (MW) was analysed by correlating both 
Table 3 - Atomic Diffusion Volume increments based on Fuller, 1966 and 1969 
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parameters as represented in Figure 2. Simultaneously, we compared the 
molecular diffusion volumes calculated through the different two atomic 
increments. 
 
 
 
A high linear relationship was indeed found between these two parameters, and 
thus for the compounds missing the molecular diffusion volume (SVcomp), it 
was calculated through the equation:  
Fuller, 1966:  𝑆𝑉𝑐𝑜𝑚𝑝 = 1.038𝑀𝑊 − 19.86     R2=0.91 
Fuller, 1969: 𝑆𝑉𝑐𝑜𝑚𝑝 = 1.05𝑀𝑊 − 19.56      R2=0.92 
The difference between atomic increments described in Fuller, 1966 and Fuller 
1969 is that for the latter ones more experimental replicates were added refine 
the atomic increments. Indeed, SVcomp calculated through Fuller, 1969 atomic 
increments have a slightly better correlation with MW. Therefore, Fuller et al, 
1969 increments were used in this report.  
3.2. Molar Volume 
Molar Volume (MV) in cm3/mol was found for 123 compounds. To understand if 
the missing values could as the Molecular Diffusion Volume, come from the 
Molecular Weight, a scatter plot was made using the found values of Molar 
Volume (Figure 3). 
Figure 2 - Scatter plot of Molecular Weight against the respective calculated Molecular 
Diffusion Volume calculated through Fuller, 1966 (Black dots and continuous black line) and 
Fuller,1969 (grey dots and discontinuous grey line). The lines result from the regression of all 
presented data points. 
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Again, a high linear correlation (R2=0.90) was found and, therefore, the missing 
values for Molar Volume were calculated through the equation: 
𝑀𝑉 = 0.8003𝑀𝑊 + 0.5764 
3.3. LogKow 
The experimental values for 109 chemical compounds were found at least in one 
of the web chemicals databases, and when two values were available, the 
average was used. For the remaining compounds, predicted values had to be 
used. To understand the differences between predictive tools and potentially if 
one of them was more reliable, an analysis between found experimental values 
and respective predictions was made. The linear correlation between the several 
sources of logKow found was very similar, as seen in Table 4:   
 
Table 4 - Trend lines equations and correlation coefficient of experimental and predicted LogKow. 
 
ACD/Labs EPI-Suite Chemicalize 
Chemical 
Dashboard 
Eq.trendline 
Pred= 
0.9929Exp+0.0291 
Pred= 
0.9597Exp+0.0056 
Pred= 
0.9355Exp+0.0453 
Pred= 
0.9070Exp+0.1386 
R2 0.96 0.93 0.87 0.94 
 
Both prediction models from EpiSuite and from Chemical Dashboard are based 
on the same PHYSPROP data, a collection of datasets, some coming from as 
early as the late 80s. However, several errors and inaccuracies have been 
reported and Chemical Dashboard developers have addressed this issue for 
some parameters such as logKow, by developing an automated curation 
procedure. The QSAR (quantitative structure-active relationship) resulting from 
this curated datasets indeed had statistically improved predictive performance 
38. 
Figure 3 - Scatter plot of Molecular Weight against the respective Molar Volume. Black line is the 
regression line drawn through all presented data points. 
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Besides, Chemical Dashboard models comply with the OECD principles for 
QSARs39, with unambiguous algorithms, a defined global and local applicability 
domain, mechanistic interpretations of the used descriptors that are reduced to 
the most relevant minimum, and with available information on the overall model 
performance. Moreover, the model is transparent, allowing access to the training 
and test sets from its FTP site, detailed QSAR Model Reporting Format for each 
model and model details for each chemical and each endpoint. All used 
descriptors are also free and open source (PaDEL descriptors) [Dr.Anthony 
Williams USA.EPA private communication]. 
Therefore, after the experimental data, Chemical Dashboard predictions were 
the ones used preferentially for following the OECD guidelines and having 
revised database for their prediction-model development. When these 
predictions were not present, the average of the other predictive tools was used.  
3.4. Henry Law Constant 
For 57 compounds the experimental values were found. Among the 33 
compounds with experimental values found in both web databases, only 5 had 
different values. The largest difference was found with hexachlorobenzene with 
values differing 82 Pa*m3/mol between them. Hence, the average of 
experimental values was used. Again an analysis was made to decide upon the 
predictions to be used, here including different methods: Group, Bond and 
HENRYWIN™ method, which uses both Group and Bond method. Because HLC 
values were removed from Chemical Dashboard in the in middle of August 2016, 
for around 40 chemicals, HLC values were found only in Chemspider. Therefore, 
for comparison of methods/databases these 40 chemicals were excluded, and 
the remaining chemicals which experimental data was found, were introduced in 
a chart to measure the correlations between predictions and the respective 
experimental values. The chemical 1,1,1-trichloroethane was also excluded since 
its HLC is much higher than any of the other compounds and could unbalance 
the distribution.  
The plot in Figure 4 shows relevant differences between the predictions with 
HENRYWIN™ showing the weakest correlation and Group Method the highest 
correlation (Table 5). Values retrieved from Chemical Dashboard also have a 
relatively weak correlation. 
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Since the values of Henry Law Constant spread in such a wide range, Figure 4 
does not allow observation of the lower HLC values distribution. Thus, a 
separated analysis was additionally made using a HCL value of 1. The selection 
of this threshold is, nevertheless, subjective.  
 
 
Figure 5 and Table 5 show the drastic different coefficients of distribution 
between the two plots, with predicted HLCs having a better correlation with 
experimental values >1 Pam3/mol than the lower ones. Hence, predictions 
suffer a decrease of sensitivity for small HLC values, with the Bond method 
showing the highest correlation. A lower sensitivity in HLC values lower than 1 
might not have a significant impact as any of the predictions indicate that the 
compound does not evaporate. However, it is noteworthy the presence of some 
predictions, such as the ones for lindane and formaldehyde, where in spite of 
low experimental HLC values, predicted values are among ranges where 
significant evaporation might occur. This can lead to significant different results, 
ex: lindane experimental value was 4.2110-1 while all predictions except the 
Figure 4 - Scatter plot of Experimental Henry Law Constant against the respective Predictions 
obtained through Bond, Group, HENRYWINTM (EPI method) and Chemical Dashboard 
(CompTox) (Units =Pa*m3/mole). 
Figure 5 - Scatter plot of Experimental Henry Law Constant, against the respective Predictions 
obtained through Bond, Group, HENRYWINTM (EPI method) and Chemical Dashboard (CompTox) 
(Units =Pa*m3/mole). 
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Group Method would indicate values 1.28-25.9 and formaldehyde experimental 
was 3.4110-2 while all the methods except Chemical Dashboard indicated values 
6.22-53.4. 
Although Chemical Dashboard HLC predictions are here shown with a relative 
low correlation with experimental data, its predictive model, as the one for 
logKow, was based on a well curated data and follows OECD guidelines, hence 
being a trustworthy tool. Still, as this parameter was temporary removed from 
the website, EPIsuite predictions were preferably used.  
In total, at least one HLC was found for 148 chemicals. Experimental data found 
for the compounds with higher HLC, ranged from the 1740 of 1,1,1-
trichloroethane to 1.7610-7 of urea. For the compounds which experimental 
data were not found, the priorities of predictions were: Group Method which 
ranged compounds with HLC = 0.3670-2.8510-15 (N=17); Bond Method which 
ranged compounds with HLC = 66.2-2.76010-37 (N=62) and at last CompTox 
Dashboard which ranged compounds with HLC =23.41-1.88010-6(N=12).   
 
3.5. VCBA Code Refinement  
The VCBA model was initially created in Matlab30,31 and more recently translated 
to R language to be a free toll for users and to be implemented in a KNIME 
environment. The differential equations describing the mass balance resulting 
from fate, cell dynamics and toxicodynamics are solved by the DeSolve R 
package. With time several versions of the VCBA code were created, all with 
slight modifications. Therefore, before running the chemicals a revision was 
made of all the versions, verifying all equations and input parameters such as 
cell and experimental input parameters. The code was harmonized and cleaned 
of redundant/duplicated equations, with the final form presented in annex 1. 
 
Table 5 - Trend lines equations and correlation coefficient of experimental and predicted Henry 
Law Constants 
Method/ 
Database 
HLC Complete Range HLC >1 HLC <1 
Eq. trendline R2 N Eq. trendline R2 N Eq. trendline R2 N 
Bond  Y=1.28x+3.62 0.74 45 Y=1.26X+8.63 0.69 18 Y=4.94X+0.71 0.05 27 
Group Y=1.08X+8.15 0.90 35 Y=1.05X+19.56 0.88 17 Y=0.10X+0.48 < 0.001 17 
HENRYWIN™  Y=1.54X+6.40 0.57 47 Y=1.52X+14.6 0.51 18 Y=-0.73X+2.88 < 0.001 27 
Chemical 
Dashboard 
Y=0.706X+10.86 0.67 47 Y=0.65X+29.85 0.60 17 Y=-3.52X+2.57 0.02 27 
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3.5.1. Cell line parameters 
The values herein used (Table 6) were the same as in Zaldivar et al21except the 
protein intracellular concentration which was corrected from 11 mol/m3 to 4.4 
mol/m3. The value was obtained from the protein density and fraction and cell 
volume.  
In order to allow inputs of different initial cell numbers, the initial cell number 
per cell cycle phases must be in fraction/percentage, then multiplied by the 
overall initial cell number, rather than a fixed value. However, care should be 
taken with the initial cell number input as 3T3 BALB/C cells have their growth 
inhibited when confluent (50,000 cells/cm2) and, therefore, the initial cell 
number must allow growth during 48 hours without reaching this confluence. 
Higher initials cell numbers would require another type of fecundity functions.   
 
Table 6– Cell line 3T3 Balb/c defined parameters to run the VCBA model. 
3T3 Cell Parameters 
Aqueous Fraction (% weight) 0.614  
Protein Fraction 0.244 
Lipid Fraction 0.142 
Protein Concentration (mol/m3) 4.4  
Lipid Concentration (kg/m3) 170.7  
Initial Cell number (per well) 1680 
Cell Cycle phase G1 S G2 M 
Duration (H) 9.63 3.65 3.45 2.26 
Mortality (h-1) 0.005 0.005 0.04 0.04 
Volume (m3) 1.73E-15 2.4E-15 2.4E-15 2.4E-15 
Mass (g) 2.08E-9 2.4E-9 2.4E-9 2.4E-9 
Initial Cell Population (%) 50.7 19.2 18.18 11.92 
Cell Division Rate (h-1) 1.026    
 
3.5.2. Experimental set up 
Likewise to cell type descriptors, experimental parameters had to be revised and 
harmonized with the experimental protocol, such as the 48 hours of duration of 
the assay, the percentage of supplemented serum of 5 %, which consists in 
0.0234 mol/m3 (protein content) and 0.08 kg/m3 (lipid content) and the 100 µL 
of media in a 96 well-plate well. Experimental data are available for 8 
concentrations for which cells were exposed at the beginning of the 48 hours. 
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3.6. Optimization and running the VCBA 
Optimization of NEC and Kr was made with the chemicals input parameters and 
experimental concentration-response curve, consisting in 8 concentrations and a 
value linked to the control response (which is included as a response of 100% at 
0 µM).  
The code was run on R, with cell growth in hours and differential equations 
solved using a discretization in seconds as shown in Figure 6. The time run can 
be adjusted to run in minutes or other time endpoints as long as the cell growth 
rates are set to the correct time units. However independent of the time run 
because compound distribution is represented by differential equations and cell 
growth is not, the two processes are not synchronized in the model. For example 
in time run herein used for every second in one hour the distribution is 
calculated with the initial cell number in that hour. At the end of the hour, the 
model computes the cell growth/death that occurred during that hour with the 
compound distribution given in the end of the hour and not during all the 
seconds. This specific time was chosen to make optimization a faster process, as 
cell growth/death in minutes makes VCBA run more cycles slowing down the 
optimization process. 
 
Table 7 – Experimental set up according to Neutral Red 
Uptake protocol. 
Water density (g/L) 1000 
Protein density (g/L) 1350 
Lipid density (g/L) 900 
Assay time (h) 48 
% Supplemented serum 5 
Protein in Medium (mol/m3) 0.0234 
Lipid in Medium (kg/m3) 0.08 
Volume Medium (m3) 1E-7 
Headspace volume (m3) 2.68E-07 
Cell assay surface (m2) 3.31E-05 
Plastic surface (m2) 9.39E-05 
Figure 6- Representation of the VCBA model's 
differential equations and "for cycle" solving. 
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Implementation of the VCBA in KNIME for use as a web tool 
The VCBA R code was implemented as an open source tool into the KNIME 
platform. KNIME is a user-friendly graphical workbench for data analysis 
(http://www.KNIME.org/) and R is a language and environment for statistical 
computing and graphics (http://www.r-project.org/). KNIME consists of a series 
of pieces of program code called nodes that can be connected in such way that 
the input of one node is the output of the previous one. Each node has a dialog 
box that accepts the user input. 
This VCBA KNIME represented in Figure 7, can be divided in to three separate 
zones: input, core and output, this version of the VCBA is only for single 
exposure simulation.  
21 
 
 
 
Figure 7 - KNIME workflow for the current VCBA where three zones are defined: input, model (core), and output. 
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3.7.  Sensitivity analysis 
Local sensitivity analysis was made for the impact of the logKow, MV, SVcomp, Kr 
and HLC parameters on the dissolved concentration (M) for different compounds 
(caffeine, benzene, xylene, ochratoxin A and dimethyldioctadecylammonium 
chloride) with the chemical IC50 calculated from the concentration-response 
curves and NEC and Kr calculated for the initial input parameters. 
For each parameter its original value was changed to  10 %, maintaining other 
parameters constant40. The normalised sensitivity coefficient (SC) was calculated 
using the equation: 
 
𝑆𝐶 =
𝐷′ − 𝐷
𝑃′ − 𝑃
×
𝑃
𝐷
 
where D is the initial outcome of the model, which in this case is the dissolved 
concentration (M) and D is the output of the model after the 10% parameter 
change. P is the initial parameter value, and P′ is the parameter value modified 
by an increase/decrease of 10%. The sensitivity analysis was conducted for 5 % 
serum, 48 hours and the previously obtained respective IC50. 
 
3.8. Statistical analysis 
GraphPad Prism 3.0 (San Diego, CA) was used for plotting and analyzing the 
data, except for Figure 6 which was made directly in R console. 
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4. Results and discussion 
For 35 out of the initial 178 compounds, we could not find either the HLC or the 
air and water half-lives, and for other 9 compounds (di-isodecyl phthalate, 
tris(nonylphenyl)phosphite, hexachlorobenzene, 2-ethylhexyl acrylate, 1,2-
dichlorobenzene, 1,1,1-trichloroethane, aconitine, 1,2-benzenedicarboxylic acid, 
malononitrile) the concentration-response curves were considered not to be 
suitable to optimize the VCBA. It is notable that 5 of these compounds (1,1,1-
trichloroethane HLC=1740, 1,2-dichlorobenzene HLC=195, hexachlorobenzene 
HLC=131, tris(nonylphenyl)phosphite HLC=66.2, 2-ethylhexyl acrylate 43.8) are 
among the 11 compounds with the highest HLC values and, thus, a prevalence 
of evaporation might have a role in the difficulties found in the in vitro assays.  
Therefore 83 compounds were optimized and run using the VCBA. The 
optimization was done after harmonization of the VCBA code, and was 
performed by applying the available in vitro concentration response curves. The 
VCBA values that were optimized (NEC and Kr) are presented in annex II. In 
Figure 8 it is exemplified for some compounds how the VCBA with the optimized 
parameters can modulate concentrations throughout the time in culture and its 
effect on cells growth/death. 
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Hexachloropene 
CAS 70-30-4 
Benzyl Benzoate 
 CAS 120-51-4 
 
  
Acetyl Salicylic Acid 
CAS 50-78-2 
Xylene 
CAS 1330-20-7 
  
Figure 8-Plots for chemical compounds concentration and effect in cell number with the optimized 
NEC and Kr: Percentage of viability at 48 hours with the nominal concentration: black line-
prediction; red dots-experimental values; Relative number of cells, Dissolved Concentration and 
Intracellular Concentration throughout the 48 hours of the culture for at least 10 concentrations of 
each compound, represented with a gradient blue color from the lower concentrations=light color 
to higher concentrations=darker color (Hexachlorophene 510-6 to 510-5 (M), Benzyl Benzoate 
0.0012 to 0.012 (M), Acetyl Salicylic Acid : 0.0028 to 0.028 (M) and Xylene: 0.0026 to 0.026 (M)) 
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4.1. Influence of logKow and HLC in chemical partitioning 
The logKow has a high impact on description of the chemical partitioning with 
lipid, plastic, protein and cellular uptake. Therefore, is expected that the 
obtained chemical compounds partition among these several compartments has 
a strong correlation with logKow. Indeed, sorting the chemical compounds from 
the highest to the lowest logKow and plotting their partition in Figure 9 
corroborates the strong influence logKow has on the chemical fate partition. Even 
though the model requires other parameters which widely vary among the 
compounds, the lipophilicity, here represented by the logKow, seems 
determinant: for the 14 chemicals with logKow higher or equal to 4.46 
(phenantrene has logKow of 4.46) less than 10% of the chemical was dissolved in 
the medium. Still, for different logKow ranges, different compartments of the in 
vitro system will be the strongest sequesters of the chemical. Observing from 
bottom to top of Figure 9 from logKow 1.88 (triethylene glycol dimethacrylate) 
the dissolved concentration starts to decrease in detriment to protein bound 
chemical until logKow 3.83 (endosulfan) in which lipid gradually binds to more 
chemical, eventually sequestering chemical even from protein binding. Although 
there is a significant binding to plastic it is never higher than 18 % 
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As for the evaporation, the VCBA model indicates that just for the two chemical 
compounds with higher HLC, benzene (HLC= 562 Pam3/mole) and xylene 
LogK
ow
 
Figure 9- Partition in the several components of the in vitro assay for the 83 compounds 
optimized and run in the VCBA model. Represented in % to total final concentration 
-2.68 
8.39 
4.46 
25 
 
(HLC=525 Pam3/mole), the percentage of compound that evaporates is higher 
than 10 %. For 1,2,4-trichlorobenzene that has a HLC of 144 Pam3/mole, just 
1% evaporates.  
Although chemical partition has a very high impact on its free dissolved 
concentration after 48 hours, attention should also be paid to degradation 
hallmark which is considered in the VCBA model. Herein, the difference between 
total initial nominal concentration and total final concentration was considered as 
an indication of degradation of chemicals. Degradation and its descriptors are 
shown in Table 8. Comparing the final concentration with the initial one of each 
chemical, xylene stands out with the most degradation as its final concentration 
is approximately half of the initial one. Benzene follows with 30 % degradation. 
Both chemicals do not have relatively high degradation rates. But in general air 
degradation rate is higher than water, hence the higher the percentage of 
chemical in the headspace the fastest the degradation of the chemical, 
highlighting the importance of the HLC as an indicator of chemical kinetics. All 
remaining chemicals were not predicted to have more than 15 % degradation. It 
is noteworthy that overall degradation of a chemical does not depend solely of 
specific degradation rates but also on its partition. Comparing the ratio of total 
final concentration/initial concentration with air degradation there is no 
correlation while for water there is a slight trend (R2=0.37). Still, these 
degradation rates will only affect chemicals that are either in the aqueous or gas 
phase. Chemical bound to protein, lipid or plastic is not considered in the VCBA 
to be protected from degradation. Therefore, comparing the total final 
concentration/initial concentration with the percentage of chemical in headspace 
and dissolved in medium, there is a slight inverted correlation (R2=3.22). By 
analyzing all these parameters together (Table 8) with a colour scale pattern it 
can better perceived how degradation is a multifactorial event.  
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Table 8 – Fraction of chemical degraded ([Final]/[Initial] and the parameters describing it, Air 
and water degradation rate (s-1) and amount of unbound chemical, meaning chemical 
available for degradation at 48 hours. The colour coding is a gradient from the lower values 
coloured red to the highest values coloured green relative to each column/parameter. 
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4.2. Influence of the experimental set up on chemical partitioning  
With external lipid and protein playing such a relevant role in chemicals 
partition, we further explored how different percentage of supplemented serum 
could influence the partition of compounds. Sixteen compounds were selected 
and simulations run with 0, 5, and 10% of serum by changing the initial protein 
and lipid concentrations. The compounds were chosen to spread across the 
range of logKow (from dimethyldioctadecylammonium chloride with 8.392 to 
ammonium chloride with -2.68) including the two compounds with significant 
evaporation (benzene and xylene).  
Figure 10, indicates substantial differences between 0% and the other two plots. 
No chemical fraction is bound to protein under 0% serum, and although there is 
an increase in the dissolved concentration, most is halted by lipid binding. In the 
absence of serum, binding to lipids is high despite the fact that proteins and 
lipids come solely from exudes from cell death. In the absence of serum also it 
has been described the relevance of plastic binding23. Observing the equations 
that describe these partitions, the distribution of chemical in the several 
elements is easily perceived: 
Plastic partition constant: Kp=10(0.97*logkow-6.94) 
 
Protein partition constant : Ks<-10(vals-1.178) 
vals={
−1.31, 𝑖𝑓 𝑙𝑜𝑔𝐾𝑜𝑤 < 1.09
0.57 × 𝑙𝑜𝑔𝐾𝑜𝑤 + 0.69, 𝑖𝑓 1.09 ≤ 𝑙𝑜𝑔𝐾𝑜𝑤 
𝑙𝑜𝑔𝐾𝑜𝑤 − 1.3, 𝑖𝑓 𝑙𝑜𝑔𝐾𝑜𝑤 > 4.6
≤ 4.6 
 
Lipid partition constant : Kl<-10(1.25*logkow-3.70) 
LogKow has a higher impact on lipid partition than on plastic for all range of 
values while for proteins the relation logKow protein-binding partition depends on 
the logKow values. For logKow values lower than 1.09 and higher than 3.7 
proteins exhibit the highest chemical binding. Partition also depends on the 
concentration of lipids and proteins and the surface area of the plastic. It should 
be noticed that although in the absence of serum the lipids in medium after 48 
hours would be one eight of the lipid content in 5 % serum supplementation, it 
still has a high binding ability as observed in the Figure 8. Indeed, two facts 
contribute for the 0 % serum plot to be far from reality. Firstly, actually at 0 % 
serum most cell lines do not grow and thus the lipids in the medium would even 
be a smaller fraction. Secondly, saturation is herein not being included. 
Experimentally, plastic partition does seem to change with nominal 
concentration26. As for lipids, saturation is also expected although it would be a 
difficult parameter to modulate as the interactions of lipids with chemicals occurs 
more in the form of aggregates than individually41.  
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Figure 10- Partition in the several components of the in vitro assay for the 16 compounds 
optimized and run in the VCBA model with 0, 5 and 10 % of supplemented serum (FBS) for 48 
hours with the previously optimized NEC and Kr. 
 
Saturation modelling could furthermore increase the differences among the 
several percentages of serum supplementation. Although the lipid binding extent 
is something that should alert for a careful consideration of the chemical's 
kinetics, a high lipid binding ability might also indicate a mode of toxicity24 based 
on narcosis which can also occur by external cell effects, without cell uptake. 
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Although VCBA simulates for very highly lipophilic chemicals very low dissolved 
concentration, uptake and bioaccumulation also depend on lipophilicity and, 
therefore, compensates to some extent for the lack of bioavailable chemical.  
Indeed, a comparison of the intracellular concentration with the dissolved 
concentration shows lack of correlation (Figure 11). In fact, segmenting the 
chemicals between the ones with logKow lower than 2.5 and the ones higher 
(red) resulted in a much more significant correlation for the ones with lower 
logKow values.  
 
Figure 11- Comparison of the logarithms of intracellular concentration and dissolved one for the 83 
simulated chemicals with 5 % serum supplementation. Red dots correspond to the chemicals with 
logKow higher than 2.5. 
Although initially serum seems to have a major role in sequestering chemicals 
from the dissolved phase, lipids originated in cells and plastic act as the major 
sequesters in the absence of serum. Also for the two compounds for which 
evaporation was predicted by VCBA, xylene and benzene, evaporation increases 
in the absence of serum which is on agreement with Kramer N. et al 200918, 
which experimentally verified that serum retained phenantrene in solution.  
 
In the same article, Kramer et al also report a possible deficiency in the model in 
capturing evaporation, for it uses as a proxy of evaporation the HLC which is 
obtained/predicted for 20-25 C, while experiments often use higher 
temperatures such as 37 C. And HLC, being dependent of the chemical solubility 
and vapour pressure, does increase with temperature. Ten Hulscher42 reported 
that for temperatures increases from 20 to 30 C, HLC increased ~50 % for 
chlorobenzene, chlorobiphenyls and polycyclic aromatic hydrocarbons. 
Evaporation of phenantrene and 1,2,4‐trichlorobenzene was experimentally 
verified18, while our model only points to 0.01%, 1.05 % of the respective 
chemical in the headspace (at 5 % supplemented serum). 
Stadnicka-Michalak J. et al 43al also verified substantial evaporation from 1,2,3 
trichlorobenzene, naphthalene and hexachlorobenzene.  
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Similarly, several reports 44,45 have indicated that compounds with 1 Pa.m3 /mol  
may be already prone to evaporate, while with 100 Pa.m3 /mol  (which would 
include 1,2,4-Trichlorobenzene) are even considered highly volatile. Therefore, 
for the compounds 1,2,3,4-tetrachlorobenzene, pentachlorobenzene, diethyl 
phthalate, p-benzoquinone, endosulfan, phenanthrene, ethyl chloroacetate, 
acetonitrile, benzaldehyde, tetramethylthiuram monosulphide, tert-Butyl 
hydroperoxide, benz(a)anthracene, pyrene, acetophenone we should have 
obtained higher percentages in the headspace while, in fact, none was modelled 
to evaporate more than 0.2%. 
4.3. Proposal of LogKow thresholds to rank chemicals  
One of the purposes of this work was to possibly create a system that alerts for 
chemicals for which the dissolved concentration is expected to differ 
substantially from the nominal one, hindering an accurate extrapolation to in 
vivo. Moreover, indications of the chemical fates in vivo can hopefully help 
refining experiments depending of the chemical properties. Therefore, to put in 
practice this alert system, the results described in Figure 8 were used to create a 
system with 4 classes (A, B, C, D) based on logKow thresholds for conditions of 
10 % serum.  
These classes and respective thresholds are represented in Figure 12. 
Chemicals with logKow below 2 are predicted by the VCBA to be at least 90% 
dissolved, constituting class D. Class C is composed by chemicals with logKow 
between 2-2.5 which are predicted to be 80% dissolved. Compounds with a 
logKow values up to 5 (class B) have dissolved concentrations in water from 5 to 
80%, showing a very strong correlation with logKow and eventually shifting the 
main chemical partition from proteins to lipids. Finally, for a logKow value 
between 5 and 10 (class A), most of the chemicals will be bound to lipids, 
migrated to plastic or bound to proteins.  
With the alerting system created we carried out an additional exercise to 
estimate the partition of chemicals not previously analyzed here in the VCBA, 
relying only on the logKow value. The chemicals chosen are a set that will be in 
the future tested for toxicity in an in vitro test system supplemented with 10 % 
serum. Hopefully, the information herein gained will help exploring the results of 
this new project. Based on Figure 12 we collected the logKow for these additional 
35 chemicals, and we ranked them based on their logKow (Table 9).  
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This resulted into 5 chemicals being of concern, thus we further investigated 
these chemicals by means of VCBA simulations, firstly collecting the other 
physical-chemical properties for these 5 chemicals. No cytotoxicity data were 
used and, therefore, the model was run with NEC and Kr set to 0, no cell death 
occurred and the impact it has on concentrations of the chemicals was tested. 
The initial concentrations used for all these chemicals were 0.1 and 100 M. Both 
concentrations induced the same % of partition. The model was run for 24 and 
72 hours but not substantial differences were found on the outputs.  
Table 9- List of chemicals, their respective logKow and class according to alert system for 
partitioning. 
  Figure 12- Proposed classes for chemical fate, delimited by thresholds based on logKow. 
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The partition of the chemicals belonging to Class A is represented in Figure 13. 
Indeed, most of the amount of chemicals is bound to lipids, proteins and/or 
plastic. For chemicals in Class B, although dissolved fraction varied greatly it was 
always less than half of the chemical total concentration after the 48 hours 
assay  
For these compounds special care should be taken when manipulating it in 
plastic eppendorfs in the laboratory, and with supplementation that should be 
done with the exact same batch of serum. 
Possible toxic mechanisms for these chemicals should be identified to find to 
what extent the dissolved concentration is responsible for cytotoxicity or if it is 
related to their lipid binding ability, destabilizing cellular membranes.  
Furthermore, for these chemicals it is advised to use used other dosimetry than 
the nominal concentration. As indicated here, nominal concentration does not 
represent the concentration the cells are indeed exposed to. This is especially 
important in the eventuality that the results generated in vitro with these 
compounds need to be extrapolated to in vivo doses. In such as case, the 
partition data shown here should be taken into account. 
 
 
 
Figure 13- Partition of the Class A and Class B chemicals through the several in vitro components 
in medium supplemented with 10 % serum and not accounting for cell death. Results from running 
the chemical at 0.1 M for a 24 hours experiment. 
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4.4. Impact of chemical partitioning on toxicity prediction 
The chemicals used were primarily tested in BALB/c 3T3 NRU in vitro assays to 
further evaluate the predictive power of the in vitro method, by comparing them 
to the acute rat oral in vivo test (mean LD50 values). This comparison was made 
through the EU CLP system for acute oral toxicity, which is based on the cut-off 
of 2000 mg/kg to assign chemicals to the classified (mean LD50< 2000 mg/kg) 
or non-classified group (mean LD50> 2000 mg/kg). In vitro IC50 were converted 
to LD50 and its resulting classification was compared to the in vivo rat oral 
classification (also based on mean LD50). The in vitro correctly classified 
chemicals were designated True (Positive and Negative), while the incorrectly 
classified were called False Positive (i.e. LD50 predicted in vitro ≤ 2000 mg/kg 
while in vivo the observed value was > 2000 mg/kg ) or Negative (i.e. LD50 
predicted in vitro > 2000 mg/kg while in vivo the observed value was ≤ 2000 
mg/kg). With the premise that the partition results would help understanding 
these false predictions of this binary classification system, and considering the 
high impact that logKow has on partitioning, it would be expected that the 
compounds which toxic class was falsely predicted, would have logKow values 
falling onto specific ranges. 
However as shown in Figure 14 this was not observed. The distribution of values 
of logKow of the compounds predicted as false positives and false negatives is not 
significantly different from the compounds with true predictions. 
 
 
 
Figure 14- Distribution of logKow of the chemical compounds which toxicity was correctly (True 
Predictions) or not correctly classified, either because in vitro indicated toxicity only at 
concentrations > 2000 mg/kg while in vivo studies shown toxic effect at lower concentrations 
(False Negative) or the opposite (False Positive). 
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After converting the nominal and predicted dissolved IC50s from molar 
concentration (M) to mg/L (mg/kg), they were plotted with the in vivo LD50, 
Figure 15, to analyze which concentration would correlate best with the in vivo 
one. The following trendline equations were obtained: 
 
log 𝑁𝑜𝑚𝑖𝑛𝑎𝑙 50 = 0.7625 × 𝐿𝐷50 − 0.1983 , R2=0.31 
log 𝐷𝑖𝑠𝑠𝑜𝑙𝑣𝑒𝑑 50 = 0.8734 × 𝐿𝐷50 − 1.076 , R2=0.20 
 
 
 
Figure 15- Comparison of the in vivo LD50 (mg/kg) with the in vitro nominal and the predicted 
dissolved IC50 (mg/kg). 
 
The logarithm of the in vivo rat oral LD50 values correlated with the logarithm of 
dissolved IC50 values has a lower coefficient of determination than with the 
nominal IC50 values. The partitioning and evaporation are events that have been 
broadly described in vitro, hence using the nominal or the actual bioavailable 
concentration for in vitro-in vivo extrapolations does make a difference. 
However, besides the uncertainties of the VCBA model, the correct way of 
integrating the predicted concentrations in this extrapolation is still being 
studied, e.g. can we assume that the dissolved concentration reflects the 
bioavailable one? Furthermore, the correlations should be interpreted in the light 
of the inherent high variability of the LD50 data, as shown by Hoffmann et al 
(2010). Moreover, the in vivo dose here being used is the nominal oral dose and 
chemical kinetics in vivo comprise more hallmarks such as metabolism and 
absorption through the gastrointestinal tract, which are being ignored in these 
comparisons. The cell line used in this assays indeed has no metabolic ability so 
it will not predict correctly the compounds that might be bio-activated or more 
easily cleared/excreted through metabolism. It is noteworthy that also the 
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higher protein-binding ability of lipophilic compound includes higher affinity with 
xenobiotic-metabolism enzymes. Thus these compounds tend to be more 
metabolized than polar compounds46 which further explain the lack of trend on 
false predictions and high logKow. However, to make a more accurate comparison 
of free unbound blood plasma concentrations in vivo and dissolved in vitro 
concentrations it would require PBK modelling all the 83 compounds, a task 
which extends beyond the scope of this specific work but hopefully will be 
explored in the future.  
As part of the ACuteTox project, kinetics transformations were used to estimate 
the oral dose from the nominal concentrations obtained in vitro (IC50) using a set 
of algorithms that took into account lipophilicity, metabolic clearance and protein 
binding and intestinal permeability using Caco-2 cells 
(http://www.acutetox.eu/WP5.pdf). The calculations were only possible for a 
limited set of compounds for which the kinetic input data were obtained and not 
clear conclusions were drawn other than recommending further evaluation 
(Prieto et al., 2013a). 
Efforts are still needed to prove that the VCBA simulations are relevant to 
predict acute oral toxicity for different regulatory contexts. In this context, an 
initial step could be to check experimentally the simulations obtained with the 
VCBA using a set of compounds. Table 10 shows the proposed compounds, 
chosen to represent a wide range of physicochemical properties and acute oral 
toxicity categories estimated in vivo and predicted in vitro. 
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Table 10 –Suggested chemical compounds to be tested in vitro, with their physical-chemical 
characteristics and the result of the comparison of the toxicity EU-CLP classification derived 
from the mean in vitro predicted and in vivo LD50s.
1
 
 MW logKow HLC 
Acute oral 
toxicity 
prediction 
 
Benzyl benzoate 212 3,97 2,3710-02 FN 
Isoniazid 137 -0,78 1,2310-09 FN 
Dimethyldioctadecylammo
nium chloride 
586 8,39 6,4510-03 FP 
Hexachlorobenzene 285 5,73 1,311002 FP 
Xylene 106 3,04 5,251002 FP 
Ethanol 46 -0,31 5,0710-01 FP 
Benzene 78 2,13 5,621002 TN 
Disulfoton 274 4,02 2,1910-09 TP 
Hexachlorophene 407 7,40 5,5510-08 TP 
Caffeine 194 -0,07 3,6310-06 TP 
 
 
 
 
 
                                           
1
 
mg/kg, non-classified: 
FN (False Negative) – in vitro toxicity was non-classified while in vivo it was classified. 
FP (False Positive) – in vitro toxicity was classified while in vivo it was non-classified. 
TN (True Negative) – both in vitro and in vivo were non-classified 
TP (True Positive) – both in vitro and in vivo were classified. Still among classified toxicity, categories : Category 1- 
mg/mL; Category 2- - - 
a chemical is considered TP, reflecting a correct prediction of classified toxicity, its category can be mispredicted; 
while Hexachlorophene category was correctly predicted, Caffeine was underpredicted for 1 category and Disulfuton 
for 3 categories 
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4.5. Sensitivity analysis of several input parameters  
A local sensitivity analysis was performed to determine how influential some of 
the input parameters are on the dissolved concentration. In Figure 16 shows the 
influence of parameters Kr, HLC and logKow on the output of the dissolved 
concentration.  
As expected the logKow is the parameter with higher impact in the dissolved 
concentration, having sensitivity coefficients higher than 0.1.  
The higher the LogKow , the higher the absolute value of sensitivity coefficient, 
showing a high impact on 4 chemicals (logKow =2.31-8.39) but not on Caffeine 
which has the lower logKow (-0.07). 
 A negative sensitivity coefficient indicates inversed relation with the output, 
which indeed is true for logKow as the higher lipophilicity, the less bioavailable 
the chemical is, e.g. for the dimethyldioctadecylammonium chloride a variation 
of 10 % on logKow value induces a change of one decimal unit in the dissolved 
concentration. Likewise for HLC, the higher its value the more the chemical 
evaporates, hence less chemical is bioavailable.   
 
 
HLC has impact on the output on the dissolved concentration of the compounds 
herein previously shown to evaporate, benzene and xylene. This supports the 
claim that under a certain threshold of HLC, in which the chemical does not 
evaporate significantly, it makes no difference how low the value is.  
A variation of 10% in the parameters of SVcomp and MV has no/very little 
impact on chemicals dissolved concentration, adding more confidence to the 
extrapolation method used to obtain these parameters from the Molecular 
Weight. Both these parameters are used in the equations of gas-liquid diffusion 
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Figure 16- Normalized Sensitivity Coefficient of the dissolved concentration upon 10 % 
increase in input parameters: Kr, HLC and logKow for 5 chemicals. 
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which describes evaporation, hence theoretically these values will only have 
impact once HLC is high enough. However, this sensitivity analysis indicates that 
even in the case of compound with high evaporation, these parameters have 
very low or negligible impact on the output.  
Killing rate has a detectable impact on the output but still it is quite low. This 
shows that although the optimization step is important, obtaining an absolute 
minimum is not essential as long as the value is closed to it. This is noteworthy 
as an analysis on the optimization process, which resulted in a 3D graph with 
the minimum error for several values of Kr and NEC, showed that in general 
VCBA minimum “lays in a very flat area” meaning that for a relative wide range 
of NEC and Kr the minimum error does not change significantly making it quite 
difficult to find the absolute minimum and thus the optimized Kr (graph not 
shown). 
4.6. Assumptions and uncertainties  
The VCBA is a model that allows analysis of any chemical as long as the 
physicochemical characteristics are obtained, additionally allowing incorporation 
of toxicological data (concentration-response curve). However, to be such a 
generic model, it was built based on several assumptions and for some groups of 
chemical compounds the uncertainty on the output may increase substantially. 
Firstly, the QSARs used in VCBA to predict partition coefficients for lipid, serum, 
and plastic, were based mostly on logKow, not including other physico-chemical 
properties important for the substance fate, such as if the chemical is a H-
donor/acceptor47. Besides, as shown below, these QSARs were derived from 
specific sets of chemicals.  
For plastic, Kramer et al26 analyzed 7 polycyclic aromatic hydrocarbons (PAHs) 
chemicals with logKow ranging 3.33 to 6.13 (and HLC from 0.034 to 45 Pa m3 
mol‐1), measuring the binding constants at 1 % maximum water solubility while 
Jonker et al 48 analyzed 13 PAHs with logKow ranging approximately 4.5 to 7. 
Solely for the protein partition’s QSAR, other chemicals than just PAHs were 
considered, as it was based on a 6 independent studies, including 36 chemicals 
with logKow ranging -1.3 to 5.1. PAHs are a family of neutral non-polar 
chemicals, hence it is not clear to what extent can we rely on VCBA outputs for 
chemicals with different characteristics. As an example, we considered protein 
binding as a non-specific interaction which is not necessarily true for polar, 
charged and more lipophobic chemicals 29. For metallorganic and inorganic 
chemicals this uncertainty further increases. Similarly, to the QSARs included in 
the VCBA, some of predictive tools/methods for the physical-chemical input 
parameters, such as the ones in EPIsuite and the Fuller method for calculation of 
molecular diffusion volume, are based on organic chemicals.  
The cell uptake in the VCBA model is based on passive diffusion and active 
transport is presently not being considered. This cell uptake rate is based on the 
specific cell surface and the permeability equation49: 
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Log permeability = −1.1711+0.98 logKow −0.0011MW 
This equation considers the molecular size and the lipophilicity (logKow) of the 
chemical molecule, parameters essential for this hallmark description, such that 
they constitute two of the five rules of the Lipinski50. However other chemicals 
characteristics such as Van der Walls surface areas also influence the cell uptake 
but as these calculations require powerful computational methods, for the sake 
of a more throughput model they were not considered 49. 
Moreover, these QSARs are not considering saturation, thus VCBA estimations 
are representative of the maximum concentration which will partition to other 
elements than aqueous. To eventually include saturation into these models 
additional experimental measurements would have to be performed such as 
determination of the maximum number of binding sites on serum protein or 
maximum concentration that can be bound to plastic26. 
HLC, as previously indicated, is a parameter measured/predicted at 
temperatures of 25 C, but it increases with higher temperatures.  Since in vitro 
experiments were obtained at 37 C, the use of this constant at 25 C, might 
cause the VCBA to under-predict this endpoint, as observed by comparing with 
literature indications of volatile chemicals.  
As for metabolism, 3T3BALB/c cells are not metabolically competent, therefore, 
in the VCBA code the rate of metabolism was set equal to 0.  
Finally, although the VCBA is run set to the same conditions of the experimental 
in vitro set up, contamination or other (e.g. cell handling) factors which could 
influence in a negative way the cell culture, are not taken into account. 
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5. Conclusions 
 From the simulations carried out with the VCBA model and the analyses 
presented in this report the following could be concluded: 
Modelling chemical fate in the in vitro set up showed how much the dissolved 
concentration can deviate from the nominal concentration for several chemicals, 
emphasising the importance of using this kind of kinetic data in the 
interpretation of in vitro studies and in in vivo-in vitro extrapolations.  
The sensitivity analysis performed showed that HLC and logKow are the most 
critical parameters. 
It is very likely that the used HLC is not representative of the most common 
temperature used in in vitro experiments (i.e. 37C). In the future, a possible 
HLC “temperature correction factor” could be developed by analysing/studying 
how HLC of several chemicals change across temperatures.  
A higher uncertainty is in the applicability of the QSAR equation describing lipid, 
protein and plastic binding. By being based on experiments made mostly with 
neutral organic compounds, such as PAH, it is not clear how will these equations 
describe chemicals prone to other types of interactions. Besides, saturation 
which is also not considered in the model, can make the model drift from reality. 
Hence, in the future, some of the obtained partitions should be tested in vitro 
using compounds spreading across a wide range of logKow and HLC.  
The low (none) impact of the 10 % variation MV and SVcomp parameters in the 
dissolved concentration output, supports the use of extrapolations of the MW, 
hence increasing the number of chemicals that can be used. Moreover, even if 
this QSAR is not totally applicable for inorganic and metallo-organic chemicals, it 
is unlikely that the difference between the predicted and the real value would 
have a high impact on the VCBA ouput.  
Using the VCBA through the development of logKow-based alert classes and in 
the future also on HLC-based classes, is promising in refinement of experimental 
designs and possibly will allow a deeper interpretation of possible problems in 
the in vitro set up, such as reproducibility. It can give chemical-specific 
indications on whether different percentages of supplementation, different time 
endpoint or microplates wells geometry will have a strong impact on the in vitro 
bioavailable concentrations and hence if some in vitro experiments are directly 
comparable or not.  
Although in vitro toxicokinetics plays a role in the discrepancy between in vivo 
data and in vitro predictions (e.g. acute oral toxicity prediction), so do the in 
vivo kinetics, and both should be considered. Therefore, the discrepancies found 
in acute oral toxicity classification between in vivo and in vitro experiments could 
be reduced and /or solved by applying PBK models.  
In order to promote the use of the VCBA model by the scientific community and 
its future application in regulatory context, it would be necessary to build 
confidence on the simulations made by checking them, to some extent, 
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experimentally. Based on the results presented in this report, a set of 10 
chemicals is proposed to start up such verification. 
In this work the dissolved concentration after 24-48 hours is assumed to be the 
“toxic dose”. However, other dosimetrics such Cmax (maximum concentration) 
and the area under the curve (AUC) of chemical concentration have been used in 
dose-response studies4 especially in repeated long-term exposure mode, which 
can be modelled by VCBA. Which dosimetric would be the most appropriate for 
in vivo models toxicity comparison, is an issue that should be further evaluated 
in the future.  
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7. List of abbreviations and definitions 
 
ADMET - absorption, distribution, metabolism, excretion and toxicity  
VCBA - Virtual Cell Based Assay 
NEC –No-effect Concentration 
Kr – killing rate 
AUC - area under the curve  
SVcomp-Molecular Diffusion Volume 
HLC- Henry Law Constant 
MV – Molar Volume 
MW – Molecular Weight 
logKow – Logarithm of the partition octanol/water 
PAH – Policyclic aromatic hydrocarbons 
TP- True Positive 
TN - True Negative 
FP - False Positive 
FN - False Negative 
LD50 – Half maximal lethal dose  
IC50 – Half maximal inhibitory concentration 
NRU – Neutral Red Uptake 
EU CLP - Classification, Labelling and Packaging of Substances and Mixtures 
QSARs – Quantitative Structure-Activity Relationships 
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Predictions obtained through Bond, Group, HENRYWINTM (EPI method) and Chemical 
Dashboard (CompTox). 
Figure 5 - Scatter plot of Experimental Henry Law Constant A) higher than 1 and B) 
lower than 1,  against the respective Predictions obtained through Bond, Group, 
HENRYWINTM (EPI method) and Chemical Dashboard (CompTox). 
Figure 6 - Representation of the VCBA model's differential equations and "for cycle" 
solving. 
Figure 7 - KNIME workflow for the current VCBA where three zones are defined: input, 
model (core), and output. 
Figure 8 - Plots for chemical compounds concentration and effect in cell number with 
the optimized NEC and Kr: Percentage of viability at 48 hours with the nominal 
concentration: black line-prediction; red dots-experimental values; Relative number of 
cells, Dissolved Concentration and Intracellular Concentration throughout the 48 hours of 
the culture for at least 10 concentrations of each compound, represented with a gradient 
blue color from the lower concentrations=light color to higher concentrations=darker 
color (Hexachlorophene 510-6 to 510-5 (M), Benzyl Benzoate 0.0012 to 0.012 (M), 
Acetyl Salicylic Acid : 0.0028 to 0.028 (M) and Xylene: 0.0026 to 0.026 (M)) 
Figure 9 - Partition in the several components of the in vitro assay for the 83 
compounds optimized and run in the VCBA model. Represented in % to total final 
concentration 
Figure 10 - Partition in the several components of the in vitro assay for the 16 
compounds optimized and run in the VCBA model with 0, 5 and 10 % of supplemented 
serum (FBS) for 48 hours with the previously optimized NEC and Kr. 
Figure 11 - Comparison of the logarithms of intracellular concentration and dissolved 
one for the 83 simulated chemicals with 5 % serum supplementation. Red dots 
correspond to the chemicals with logKow higher than 2.5. 
 Figure 12 - Proposed classes for chemical fate, delimited by thresholds based on 
logKow. 
Figure 13 - Partition of the Class A and Class B chemicals through the several in vitro 
components in medium supplemented with 10 % serum and not accounting for cell 
death. Results from running the chemical at 0.1 M for a 24 hours experiment. 
Figure 14 - Distribution of logKow of the chemical compounds which toxicity was 
correctly (True Predictions) or not correctly classified, either because in vitro indicated 
toxicity only at concentrations > 2000 mg/kg while in vivo studies shown toxic effect at 
lower concentrations (False Negative) or the opposite (False Positive). 
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Figure 15 - Comparison of the in vivo LD50 (mg/kg) with the in vitro nominal and the 
predicted dissolved IC50 (mg/kg). 
Figure 16 - Normalized Sensitivity Coefficient of the dissolved concentration upon 10 % 
increase in input parameters: Kr, HLC and logKow for 5 chemicals. 
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it, Air and water degradation rate (s-1) and amount of unbound chemical, meaning 
chemical available for degradation at 48 hours. The colour coding is a gradient from the 
lower values coloured red to the highest values coloured green relative to each 
column/parameter. 
Table 9 - List of chemicals, their respective logKow and Class according to alert system 
for partition. 
Table 10 – Suggested chemical compounds to be tested in vitro, with their physical-
chemical characteristics and the result of the comparison of the toxicity EU-CLP 
classification derived from the mean in vitro predicted and in vivo LD50s.
2 
Table 11 – Sensitivity Coefficient for parameters logKow, HLC, Svcomp, MV and Kr in 
Caffeine, Benzene, Xylene, Ochratoxin A, Dimethyldioctadecylammonium chloride. 
 
 
 
 
 
  
                                           
+ 
49 
 
10. Annexes 
Table 11 – Sensitivity Coefficient for parameters logKow, HLC, Svcomp, MV and Kr in Caffeine, 
Benzene, Xylene, Ochratoxin A, Dimethyldioctadecylammonium chloride. 
 
Chemicals 
Parameters 
Variation 
logKow HLC Svcomp MV Kr 
Caffeine 
2.1E-04 -2.0E-04 0 -2.0E-04 -2.3E-04 -10% 
-1.8E-04 2.0E-04 0 2.0E-04 1.7E-04 +10% 
Benzene 
-0.304 -0.370 0 0 -2.1E-04 -10% 
-0.410 -0.345 0 0 -1.9E-04 +10% 
Xylene 
-0.608 -0.607 1.6E-05 0 -3.6E-04 -10% 
-1.015 -0.548 1.0E-05 0 -2.4E-04 +10% 
Ochratoxin A 
-19.375 0 0 0 -0.007 -10% 
-7.087 0 0 0 -0.007 +10% 
Dimethyldioctadecylammonium 
chloride 
-99.831 0 0 0 0.003 -10% 
-9.068 0 0 0 0.006 +10% 
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http://bookshop.europa.eu. Multiple copies of free publications may be obtained by contacting Europe 
Direct or your local information centre (see http://europa.eu/contact). 
  
K
J-N
A
-2
8
6
9
4
-E
N
-N
 
doi: 10.2760/475757 
ISBN 978-92-79-70867-1 
